Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
2.120
+0.010 (0.47%)
At close: Nov 24, 2025, 4:00 PM EST
2.110
-0.010 (-0.47%)
After-hours: Nov 24, 2025, 7:30 PM EST

Repare Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
11.8753.4851.13131.837.60.14
Upgrade
Revenue Growth (YoY)
-82.16%4.58%-61.21%1634.61%5529.63%-
Upgrade
Cost of Revenue
-36.0113.3813.24116.7287.8538.78
Upgrade
Gross Profit
47.8840.137.8915.11-80.25-38.64
Upgrade
Selling, General & Admin
27.0732.2236.1534.928.4115.66
Upgrade
Research & Development
100.03100.03117.96---
Upgrade
Operating Expenses
127.09132.24154.1234.928.4115.66
Upgrade
Operating Income
-79.21-92.14-116.22-19.8-108.66-54.3
Upgrade
Interest & Investment Income
7.0210.3913.335.630.260.24
Upgrade
Currency Exchange Gain (Loss)
0-0-0.170.31-0.14-0.66
Upgrade
Other Non Operating Income (Expenses)
0.03-0.12-0.12-0.04-0.04-0.02
Upgrade
EBT Excluding Unusual Items
-72.16-81.87-103.18-13.9-108.59-54.74
Upgrade
Merger & Restructuring Charges
-8.33-1.38----
Upgrade
Other Unusual Items
3.26-----
Upgrade
Pretax Income
-71.44-83.25-103.18-13.9-108.59-54.74
Upgrade
Income Tax Expense
0.761.44-9.3815.15-1.68-1.33
Upgrade
Net Income
-72.2-84.69-93.8-29.05-106.91-53.42
Upgrade
Net Income to Common
-72.2-84.69-93.8-29.05-106.91-53.42
Upgrade
Shares Outstanding (Basic)
434242423820
Upgrade
Shares Outstanding (Diluted)
434242423820
Upgrade
Shares Change (YoY)
1.02%0.76%0.41%10.85%88.66%1211.56%
Upgrade
EPS (Basic)
-1.69-2.00-2.23-0.69-2.83-2.66
Upgrade
EPS (Diluted)
-1.69-2.00-2.23-0.69-2.83-2.66
Upgrade
Free Cash Flow
--76.45-129.1-0.28-87.49-8.32
Upgrade
Free Cash Flow Per Share
--1.80-3.07-0.01-2.31-0.41
Upgrade
Gross Margin
403.39%74.98%74.11%11.46%--
Upgrade
Operating Margin
-667.31%-172.31%-227.30%-15.02%-1429.74%-40223.70%
Upgrade
Profit Margin
-608.26%-158.37%-183.44%-22.03%-1406.68%-39568.15%
Upgrade
Free Cash Flow Margin
--142.95%-252.47%-0.21%-1151.13%-6163.70%
Upgrade
EBITDA
-75.65-90.22-114.27-17.82-107.19-53.41
Upgrade
EBITDA Margin
--168.71%-223.48%-13.52%--
Upgrade
D&A For EBITDA
3.561.921.951.981.470.9
Upgrade
EBIT
-79.21-92.14-116.22-19.8-108.66-54.3
Upgrade
EBIT Margin
--172.31%-227.30%-15.02%--
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q